AbbVie names Robert Michael as CEO effective July 1; Gonzalez to executive chairman

AbbVie Inc.

Robert A. Michael, current president & COO, will become CEO on July 1, 2024.
Richard A. Gonzalez retires as CEO after 11 years, becomes executive chairman.
Michael appointed to board as Class II director, effective July 1, 2024.
Gonzalez to remain as executive chairman; board conducted thorough succession process.
Michael played key role in Allergan, ImmunoGen, and pending Cerevel acquisitions.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Robert A. Michael

Director

ABBV · AbbVie Inc.

Effective: 2024-07-01
Filed: February 20, 2024, 6:59 PM ET

The Board also appointed Mr. Michael as a member of the Board of Directors as a Class II director, effective July 1, 2024.

Role change

Richard A. Gonzalez

Executive Chairman

ABBV · AbbVie Inc.

Effective: 2024-07-01
Successor: Robert A. Michael
Filed: February 20, 2024, 6:59 PM ET

Mr. Gonzalez, who has served as CEO since the company’s formation in 2013, will retire from the role of CEO and become Executive Chairman of the Board of Directors, effective July 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert A. Michael was appointed as Director at AbbVie Inc..

Action: appointed
Role: Director

Exact text from the filing

The Board also appointed Mr. Michael as a member of the Board of Directors as a Class II director, effective July 1, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard A. Gonzalez changed role as Executive Chairman at AbbVie Inc..

Action: become
Role: Executive Chairman

Exact text from the filing

Mr. Gonzalez, who has served as CEO since the company’s formation in 2013, will retire from the role of CEO and become Executive Chairman of the Board of Directors, effective July 1, 2024.

View on SEC.gov

AbbVie Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-025262

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.